YHB Investment Advisors’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.84M Sell
11,642
-5,767
-33% -$2.14M 0.31% 81
2026
Q1
$4.71M Sell
17,409
-831
-5% -$247K 0.34% 78
2025
Q4
$6.02M Sell
18,240
-815
-4% -$276K 0.42% 65
2025
Q3
$6.58M Sell
19,055
-10,550
-36% -$3.19M 0.48% 56
2025
Q2
$9.24M Sell
29,605
-94
-0.3% -$35.9K 0.71% 36
2025
Q1
$15.6M Sell
29,699
-1,303
-4% -$666K 1.3% 17
2024
Q4
$15.7M Buy
31,002
+178
+0.6% +$101K 1.29% 17
2024
Q3
$18M Buy
30,824
+203
+0.7% +$115K 1.49% 15
2024
Q2
$15.6M Buy
30,621
+1,322
+5% +$648K 1.34% 17
2024
Q1
$14.5M Sell
29,299
-1,972
-6% -$1M 1.29% 18
2023
Q4
$16.5M Sell
31,271
-3,743
-11% -$2M 1.59% 13
2023
Q3
$17.7M Buy
35,014
+19
+0.1% +$9.35K 1.63% 12
2023
Q2
$16.8M Buy
34,995
+534
+2% +$261K 1.57% 13
2023
Q1
$16.3M Buy
34,461
+2,425
+8% +$1.17M 1.63% 12
2022
Q4
$17M Sell
32,036
-2,117
-6% -$1.12M 1.81% 11
2022
Q3
$17.2M Sell
34,153
-38
-0.1% -$20K 1.92% 10
2022
Q2
$17.6M Buy
34,191
+44
+0.1% +$22.1K 1.85% 11
2022
Q1
$17.4M Sell
34,147
-1,639
-5% -$790K 1.54% 11
2021
Q4
$18M Buy
35,786
+712
+2% +$322K 1.42% 14
2021
Q3
$13.7M Buy
35,074
+117
+0.3% +$48.5K 1.18% 19
2021
Q2
$14M Sell
34,957
-433
-1% -$173K 1.19% 18
2021
Q1
$13.8M Sell
35,390
-71
-0.2% -$24.6K 1.2% 19
2020
Q4
$12.4M Buy
35,461
+412
+1% +$138K 1.18% 20
2020
Q3
$10.9M Buy
35,049
+11,079
+46% +$3.4M 1.19% 22
2020
Q2
$7.07M Sell
23,970
-488
-2% -$140K 1.02% 29
2020
Q1
$6.1M Buy
24,458
+1,143
+5% +$315K 1.05% 31
2019
Q4
$6.85M Sell
23,315
-911
-4% -$238K 0.98% 34
2019
Q3
$5.26M Buy
24,226
+1,028
+4% +$248K 0.8% 41
2019
Q2
$5.66M Sell
23,198
-2,517
-10% -$605K 0.9% 37
2019
Q1
$6.36M Buy
25,715
+442
+2% +$113K 1% 34
2018
Q4
$6.3M Sell
25,273
-13,933
-36% -$3.68M 1.12% 29
2018
Q3
$10.4M Buy
39,206
+2,105
+6% +$548K 1.57% 16
2018
Q2
$9.1M Buy
37,101
+482
+1% +$116K 1.49% 17
2018
Q1
$7.84M Sell
36,619
-1,222
-3% -$279K 1.33% 20
2017
Q4
$8.34M Buy
37,841
+355
+0.9% +$75.2K 1.42% 20
2017
Q3
$7.34M Buy
37,486
+15,578
+71% +$3.01M 1.31% 23
2017
Q2
$4.06M Sell
21,908
-15,642
-42% -$2.74M 0.7% 41
2017
Q1
$6.57M Sell
37,550
-682
-2% -$112K 1.26% 23
2016
Q4
$6.12M Buy
38,232
+18,265
+91% +$2.73M 1.27% 24
2016
Q3
$2.79M Sell
19,967
-20,063
-50% -$2.81M 0.67% 51
2016
Q2
$5.65M Buy
40,030
+24,715
+161% +$3.3M 1.24% 28
2016
Q1
$1.97M Sell
15,315
-26,035
-63% -$3.08M 0.53% 60
2015
Q4
$4.86M Buy
41,350
+570
+1% +$66.6K 1.1% 32
2015
Q3
$4.73M Sell
40,780
-3,250
-7% -$389K 1.12% 29
2015
Q2
$5.37M Sell
44,030
-3,575
-8% -$423K 1.17% 26
2015
Q1
$5.63M Sell
47,605
-1,175
-2% -$130K 1.26% 23
2014
Q4
$4.93M Buy
48,780
+25
+0.1% +$2.37K 1.13% 27
2014
Q3
$4.21M Buy
48,755
+200
+0.4% +$16.9K 1.01% 31
2014
Q2
$3.97M Buy
48,555
+573
+1% +$45.1K 0.96% 37
2014
Q1
$3.93M Buy
47,982
+2,450
+5% +$184K 1% 35
2013
Q4
$3.43M Buy
45,532
+800
+2% +$57.5K 0.92% 41
2013
Q3
$3.2M Sell
44,732
-275
-0.6% -$19.7K 0.95% 39
2013
Q2
$2.95M Buy
+45,007
New +$2.8M 0.92% 41

Other funds holding UNH

YHB Investment Advisors's UNH Position: Q2 2026 in Review

YHB Investment Advisors reduced its UnitedHealth (UNH) stake by 33% in Q2 2026, selling an estimated $2.14M and leaving 11,642 shares worth $4.84M. The position accounts for 0.31% of the portfolio, ranked #81.

YHB Investment Advisors first reported a position in UNH in Q2 2013 and has held it in 53 quarters since. The position peaked at $18M in Q3 2024. 1,059 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • YHB Investment Advisors held 11,642 shares of UnitedHealth worth $4.84M as of Q2 2026.
  • YHB Investment Advisors sold 5,767 UnitedHealth shares in Q2 2026, an estimated $2.14M.
  • UnitedHealth made up 0.31% of YHB Investment Advisors's portfolio in Q2 2026, its #81 holding.
  • YHB Investment Advisors first reported a position in UnitedHealth in Q2 2013 and has held it in 53 quarters since.
  • YHB Investment Advisors's UnitedHealth position peaked at $18M in Q3 2024.
  • 1,059 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on YHB Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.